HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
206:@0.078769:0.033217:0.109813:0.033217:0.109813:0.013052:0.078769:0.013052:0.010348:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
Atopic dermatitis: diagnosis and management:@0.076190:0.099847:0.832142:0.099847:0.832142:0.063183:0.076190:0.063183:0.024862:0.010079:0.021503:0.022175:0.008063:0.021503:0.009407:0.022175:0.021503:0.010751:0.031582:0.022175:0.010079:0.008063:0.010079:0.008063:0.014783:0.009407:0.009407:0.022175:0.008063:0.022175:0.022175:0.020159:0.021503:0.014783:0.008063:0.014783:0.009407:0.022175:0.020159:0.022175:0.009407:0.031582:0.022175:0.020159:0.022175:0.022175:0.021503:0.031582:0.021503:0.020159:0.010079
t isaacs:@0.076190:0.169924:0.140362:0.169924:0.140362:0.151592:0.076190:0.151592:0.007056:0.004704:0.004704:0.007392:0.011087:0.011087:0.010751:0.007392
1,2:@0.140359:0.164036:0.154000:0.164036:0.154000:0.153404:0.140359:0.153404:0.005456:0.002728:0.005456
MBChB, MFamMed, FCDerm(sA), MMed:@0.076190:0.182220:0.338402:0.182220:0.338402:0.168191:0.076190:0.168191:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.003723:0.012351:0.006518:0.009179:0.012606:0.012351:0.008735:0.009206:0.003723:0.003723:0.006518:0.010926:0.009999:0.008735:0.004045:0.012606:0.004959:0.006693:0.009945:0.004959:0.003723:0.003723:0.012351:0.012351:0.008735:0.009206
rm ngwanya:@0.076190:0.203789:0.184711:0.203789:0.184711:0.185458:0.076190:0.185458:0.009743:0.015119:0.004704:0.012431:0.011087:0.013439:0.011087:0.010079:0.009743:0.011087
2:@0.184711:0.197902:0.190167:0.197902:0.190167:0.187270:0.184711:0.187270:0.005456
MBChB, FCDerm (sA):@0.076190:0.216086:0.213646:0.216086:0.213646:0.202057:0.076190:0.202057:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.003723:0.006518:0.010926:0.009999:0.008735:0.004045:0.012606:0.003723:0.004959:0.006693:0.009945:0.004959
r lehloenya:@0.076190:0.237655:0.175304:0.237655:0.175304:0.219324:0.076190:0.219324:0.009743:0.004704:0.007392:0.010751:0.010079:0.004032:0.010751:0.010751:0.010079:0.009743:0.011087
2:@0.175311:0.231768:0.180767:0.231768:0.180767:0.221135:0.175311:0.221135:0.005456
Bsc, MBChB, FCDerm(sA):@0.076190:0.249952:0.240470:0.249952:0.240470:0.235923:0.076190:0.235923:0.007714:0.006693:0.008695:0.003723:0.003723:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.003723:0.006518:0.010926:0.009999:0.008735:0.004045:0.012606:0.004959:0.006693:0.009945:0.004959
1. Division of Dermatology, Department of Medicine,:@0.076190:0.268168:0.417639:0.268168:0.417639:0.254139:0.076190:0.254139:0.007445:0.003723:0.003723:0.009999:0.002688:0.007445:0.002688:0.005214:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.009999:0.008735:0.004045:0.012606:0.009179:0.004556:0.008803:0.002688:0.008803:0.009045:0.007203:0.003723:0.003723:0.009999:0.008735:0.009165:0.009179:0.004045:0.004556:0.012606:0.008735:0.008198:0.004556:0.003723:0.008803:0.004220:0.003723:0.012351:0.008735:0.009206:0.002688:0.008695:0.002688:0.008198:0.008735:0.003723
University of Cape Town and Red Cross War Memorial:@0.076190:0.281253:0.424573:0.281253:0.424573:0.267224:0.076190:0.267224:0.008803:0.008198:0.002688:0.007445:0.008735:0.004045:0.005214:0.002688:0.004556:0.007203:0.003723:0.008803:0.004220:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198:0.003723:0.009179:0.008198:0.009206:0.003723:0.008158:0.008735:0.009206:0.003723:0.010926:0.004045:0.008803:0.005214:0.005214:0.003723:0.012902:0.009179:0.004045:0.003723:0.012351:0.008735:0.012606:0.008803:0.004045:0.002688:0.009179:0.002688
Children’s Hospital, Cape Town:@0.076190:0.294338:0.279068:0.294338:0.279068:0.280309:0.076190:0.280309:0.010926:0.008198:0.002688:0.002688:0.009206:0.004045:0.008735:0.008198:0.004717:0.005214:0.003723:0.009179:0.008803:0.005214:0.009165:0.002688:0.004556:0.009179:0.002688:0.003723:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198
2. Division of Dermatology, Department of Medicine,:@0.076190:0.308705:0.397480:0.308705:0.397480:0.294676:0.076190:0.294676:0.007042:0.003319:0.003319:0.009596:0.002285:0.007042:0.002285:0.004811:0.002285:0.008399:0.007795:0.003319:0.008399:0.003817:0.003319:0.009596:0.008332:0.003642:0.012203:0.008776:0.004153:0.008399:0.002285:0.008399:0.008641:0.006800:0.003319:0.003319:0.009596:0.008332:0.008762:0.008776:0.003642:0.004153:0.012203:0.008332:0.007795:0.004153:0.003319:0.008399:0.003817:0.003319:0.011947:0.008332:0.008803:0.002285:0.008292:0.002285:0.007795:0.008332:0.003723
University of Cape Town and Groote Schuur Hospital, Cape Town:@0.076190:0.321790:0.474312:0.321790:0.474312:0.307761:0.076190:0.307761:0.008399:0.007795:0.002285:0.007042:0.008332:0.003642:0.004811:0.002285:0.004153:0.006800:0.003319:0.008399:0.003817:0.003319:0.010523:0.008776:0.008762:0.008332:0.003319:0.005322:0.008399:0.010765:0.007795:0.003319:0.008776:0.007795:0.008803:0.003319:0.011316:0.003642:0.008399:0.008399:0.004153:0.008332:0.003319:0.006290:0.008292:0.007795:0.007768:0.007768:0.003642:0.003319:0.008776:0.008399:0.004811:0.008762:0.002285:0.004153:0.008776:0.002285:0.003319:0.003319:0.010523:0.008776:0.008762:0.008332:0.003319:0.005322:0.008399:0.010765:0.008198
Atopic dermatitis (AD), also referred  to as atopic ec-:@0.076190:0.356946:0.480927:0.356946:0.480927:0.341163:0.076190:0.341163:0.011188:0.005125:0.009903:0.010311:0.003024:0.009782:0.006819:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.006819:0.005579:0.011188:0.011249:0.005579:0.004188:0.006819:0.010326:0.003024:0.005866:0.009903:0.006819:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.009827:0.010357:0.004188:0.002616:0.005125:0.009903:0.006819:0.010326:0.005866:0.006819:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.006819:0.009827:0.009782:0.005020
zema, is a chronic, relapsing, pruritic, inflammatory skin :@0.076190:0.371182:0.485115:0.371182:0.485115:0.355399:0.076190:0.355399:0.006426:0.009827:0.014182:0.010326:0.004188:0.004944:0.003024:0.005866:0.004959:0.010326:0.004959:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004188:0.004944:0.004551:0.009827:0.003024:0.010326:0.010311:0.005866:0.003024:0.009223:0.010175:0.004188:0.004959:0.010311:0.004551:0.009192:0.004551:0.003024:0.005125:0.003024:0.009782:0.004188:0.004944:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004944:0.005866:0.007590:0.003024:0.009223:0.004188
condition  affecting  children  and adults, that  is often :@0.076190:0.385417:0.485130:0.385417:0.485130:0.369634:0.076190:0.369634:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.003477:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.009223:0.010175:0.004188:0.003477:0.009782:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.004188:0.003477:0.010326:0.009223:0.010357:0.007680:0.010326:0.010357:0.009192:0.003024:0.005125:0.005866:0.004188:0.007680:0.005125:0.009223:0.010326:0.005125:0.004188:0.003477:0.003024:0.005866:0.007680:0.009903:0.004747:0.005125:0.009827:0.009223:0.004188
associated with  elevated serum  immunoglobulin  (IgE) :@0.076190:0.399653:0.485130:0.399653:0.485130:0.383870:0.076190:0.383870:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.006743:0.012564:0.003024:0.005125:0.009223:0.004188:0.002540:0.009827:0.003024:0.009827:0.008376:0.010326:0.005125:0.009827:0.010357:0.006743:0.005866:0.009827:0.004551:0.009192:0.014182:0.004188:0.002540:0.003024:0.014182:0.014182:0.009192:0.009223:0.009903:0.010175:0.003024:0.009903:0.010311:0.009192:0.003024:0.003024:0.009223:0.004188:0.002540:0.005579:0.003417:0.010175:0.008104:0.005579:0.004188
levels and occurs in families with atopic diseases. The :@0.076190:0.413888:0.485145:0.413888:0.485145:0.398106:0.076190:0.398106:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.006320:0.010326:0.009223:0.010357:0.006320:0.009903:0.009782:0.009782:0.009192:0.004551:0.005866:0.006305:0.003024:0.009223:0.006320:0.004747:0.010326:0.014182:0.003024:0.003024:0.003024:0.009827:0.005866:0.006320:0.012564:0.003024:0.005125:0.009223:0.006305:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.006320:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005866:0.004188:0.006320:0.006441:0.009223:0.009827:0.004188
allergic march refers to the development of atopic der-:@0.076190:0.428124:0.480972:0.428124:0.480972:0.412341:0.076190:0.412341:0.010326:0.003024:0.003024:0.009827:0.004551:0.010175:0.003024:0.009782:0.003946:0.014182:0.010326:0.004551:0.009782:0.009223:0.003946:0.004551:0.009827:0.004747:0.009827:0.004551:0.005866:0.003931:0.005125:0.009903:0.003946:0.005125:0.009223:0.009827:0.003946:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.014182:0.009827:0.009223:0.005125:0.003946:0.009903:0.004747:0.003946:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.003946:0.010357:0.009827:0.004551:0.005020
matitis in infancy followed by allergic rhinitis, asthma or :@0.076190:0.442359:0.485160:0.442359:0.485160:0.426577:0.076190:0.426577:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004899:0.003024:0.009223:0.004899:0.003024:0.009223:0.004747:0.010326:0.009223:0.009782:0.008104:0.004899:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.009827:0.010357:0.004899:0.010311:0.008104:0.004899:0.010326:0.003024:0.003024:0.009827:0.004551:0.010175:0.003024:0.009782:0.004899:0.004551:0.009223:0.003024:0.009223:0.003024:0.005125:0.003024:0.005866:0.004188:0.004899:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004899:0.009903:0.004551:0.004188
food allergy at a later age. Although considered a nat-:@0.076190:0.456595:0.480942:0.456595:0.480942:0.440812:0.076190:0.440812:0.004747:0.009903:0.009903:0.010357:0.004203:0.010326:0.003024:0.003024:0.009827:0.004551:0.010175:0.008104:0.004203:0.010326:0.005125:0.004218:0.010326:0.004218:0.003024:0.010326:0.005125:0.009827:0.004551:0.004203:0.010326:0.010175:0.009827:0.004188:0.004203:0.011188:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.004203:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.004203:0.010326:0.004218:0.009223:0.010326:0.005125:0.005020
ural progression of atopy, the march is not a universal :@0.076190:0.470830:0.485130:0.470830:0.485130:0.455048:0.076190:0.455048:0.009192:0.004551:0.010326:0.003024:0.005866:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.005851:0.009903:0.004747:0.005851:0.010326:0.005125:0.009903:0.010311:0.008104:0.004188:0.005866:0.005125:0.009223:0.009827:0.005866:0.014182:0.010326:0.004551:0.009782:0.009223:0.005851:0.003024:0.005866:0.005866:0.009223:0.009903:0.005125:0.005851:0.010326:0.005866:0.009192:0.009223:0.003024:0.008376:0.009827:0.004551:0.005866:0.010326:0.003024:0.004188
phenomenon.:@0.076190:0.485066:0.181222:0.485066:0.181222:0.469283:0.076190:0.469283:0.010311:0.009223:0.009827:0.009223:0.009903:0.014182:0.009827:0.009223:0.009903:0.009223:0.004188
1:@0.181204:0.479798:0.186062:0.479798:0.186062:0.470644:0.181204:0.470644:0.004858
ePiDemiOlOGy:@0.076190:0.518083:0.211825:0.518083:0.211825:0.497918:0.076190:0.497918:0.009609:0.010348:0.005174:0.012935:0.009609:0.016631:0.005174:0.015522:0.008131:0.015522:0.015522:0.011457
Atopic dermatitis affects 10-20%  of children in devel-:@0.076190:0.534100:0.480957:0.534100:0.480957:0.518317:0.076190:0.518317:0.011188:0.005125:0.009903:0.010311:0.003024:0.009782:0.007287:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.007287:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.007287:0.008376:0.008376:0.005020:0.008376:0.008376:0.011717:0.004188:0.003115:0.009903:0.004747:0.007287:0.009782:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.007287:0.003024:0.009223:0.007287:0.010357:0.009827:0.008376:0.009827:0.003024:0.005020
oped countries and 1-3% of adults.  In south Africa, a :@0.076190:0.548335:0.485145:0.548339:0.485145:0.532556:0.076190:0.532553:0.009903:0.010311:0.009827:0.010357:0.006123:0.009782:0.009903:0.009192:0.009223:0.005125:0.004551:0.003024:0.009827:0.005866:0.006123:0.010326:0.009223:0.010357:0.006123:0.008376:0.005020:0.008376:0.011717:0.006138:0.009903:0.004747:0.006123:0.010326:0.010357:0.009192:0.003024:0.005125:0.005866:0.004188:0.004868:0.006123:0.003417:0.009223:0.006138:0.007529:0.009903:0.009192:0.005125:0.009223:0.006123:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.006123:0.010326:0.131172
2:@0.339844:0.543040:0.344702:0.543040:0.344702:0.533886:0.339844:0.533886:0.004858
developing country,  the one-year prevalence rate :@0.076190:0.562574:0.485145:0.562574:0.485145:0.546792:0.076190:0.546792:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.003024:0.009223:0.010175:0.010961:0.009782:0.009903:0.009192:0.009223:0.005125:0.004551:0.008104:0.004188:0.004188:0.006758:0.005125:0.009223:0.009827:0.010961:0.009903:0.009223:0.009827:0.005020:0.008104:0.009827:0.010326:0.004551:0.010961:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.010961:0.004551:0.010326:0.005125:0.009827:0.004188
amongst 13-14-year olds in Cape Town was 8.3-13.3%, :@0.076190:0.576810:0.485115:0.576810:0.485115:0.561027:0.076190:0.561027:0.010326:0.014182:0.009903:0.009223:0.010175:0.005866:0.005125:0.006078:0.008376:0.008376:0.004415:0.008376:0.008376:0.005020:0.008104:0.009827:0.010326:0.004551:0.006078:0.009903:0.003024:0.010357:0.005866:0.006093:0.003024:0.009223:0.006078:0.012292:0.010326:0.010311:0.009827:0.006078:0.006441:0.009903:0.012564:0.009223:0.006078:0.012564:0.010326:0.005866:0.006093:0.008376:0.004188:0.008376:0.004415:0.008376:0.008376:0.004188:0.008376:0.011717:0.004188:0.004188
with 2.3% being severe.  In 3- to 11-year-old Xhosa chil-:@0.076190:0.591045:0.480936:0.591055:0.480936:0.575273:0.076190:0.575263:0.012564:0.003024:0.005125:0.009223:0.004853:0.008376:0.004188:0.008376:0.011717:0.004868:0.010311:0.009827:0.003024:0.009223:0.010175:0.004853:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188:0.004863:0.004853:0.003417:0.009223:0.004853:0.008376:0.005020:0.004868:0.005125:0.009903:0.004853:0.008376:0.008376:0.005020:0.008104:0.009827:0.010326:0.004551:0.005020:0.009903:0.003024:0.010357:0.004868:0.009207:0.009223:0.009903:0.005866:0.010326:0.004853:0.009782:0.009223:0.003024:0.003024:0.080274
2:@0.248384:0.585757:0.253242:0.585757:0.253242:0.576603:0.248384:0.576603:0.004858
dren,  the one-year prevalence rate  was 1-2.5%, with :@0.076184:0.605291:0.485139:0.605291:0.485139:0.589508:0.076184:0.589508:0.010357:0.004551:0.009827:0.009223:0.004188:0.004188:0.003205:0.005125:0.009223:0.009827:0.007408:0.009903:0.009223:0.009827:0.005020:0.008104:0.009827:0.010326:0.004551:0.007408:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.007408:0.004551:0.010326:0.005125:0.009827:0.004188:0.003205:0.012564:0.010326:0.005866:0.007408:0.008376:0.005020:0.008376:0.004188:0.008376:0.011717:0.004188:0.007408:0.012564:0.003024:0.005125:0.009223:0.004188
increased prevalence in urban environments.  Atopic :@0.076184:0.619526:0.485140:0.619533:0.485140:0.603751:0.076184:0.603744:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006864:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.006864:0.003024:0.009223:0.006864:0.009192:0.004551:0.010311:0.010326:0.009223:0.006864:0.009827:0.009223:0.008376:0.003024:0.004551:0.009903:0.009223:0.014182:0.009827:0.009223:0.005125:0.005866:0.004188:0.004869:0.006864:0.011188:0.005125:0.009903:0.010311:0.003024:0.009782:0.037946
3:@0.419895:0.614235:0.424753:0.614235:0.424753:0.605081:0.419895:0.605081:0.004858
dermatitis starts most commonly between three- to six :@0.076185:0.633769:0.485110:0.633769:0.485110:0.617986:0.076185:0.617986:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.005957:0.005866:0.005125:0.010326:0.004551:0.005125:0.005866:0.005957:0.014182:0.009903:0.005866:0.005125:0.005957:0.009782:0.009903:0.014182:0.014182:0.009888:0.009223:0.003024:0.008104:0.005957:0.010311:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.005942:0.005125:0.009223:0.004551:0.009827:0.009827:0.005020:0.005942:0.005125:0.009903:0.005942:0.005866:0.003024:0.007257:0.004188
months of age, with 60% of cases developing in the first :@0.076185:0.648004:0.485140:0.648004:0.485140:0.632222:0.076185:0.632222:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004385:0.009903:0.004747:0.004400:0.010326:0.010175:0.009827:0.004188:0.004400:0.012564:0.003024:0.005125:0.009223:0.004400:0.008376:0.008376:0.011717:0.004400:0.009903:0.004747:0.004400:0.009782:0.010326:0.005866:0.009827:0.005866:0.004400:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.003024:0.009223:0.010175:0.004400:0.003024:0.009223:0.004400:0.005125:0.009223:0.009827:0.004400:0.003681:0.003681:0.004551:0.005866:0.005125:0.004188
year of life, and 90% before the age of five years. While :@0.076185:0.662240:0.485110:0.662240:0.485110:0.646457:0.076185:0.646457:0.008104:0.009827:0.010326:0.004551:0.004339:0.009903:0.004747:0.004339:0.003024:0.003024:0.004747:0.009827:0.004188:0.004339:0.010326:0.009223:0.010357:0.004339:0.008376:0.008376:0.011717:0.004339:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.004339:0.005125:0.009223:0.009827:0.004339:0.010326:0.010175:0.009827:0.004339:0.009903:0.004747:0.004339:0.003681:0.003681:0.008376:0.009827:0.004339:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.004339:0.014514:0.009223:0.003024:0.003024:0.009827:0.004188
the majority resolve, 10-30% persist into adulthood.:@0.076185:0.676475:0.443018:0.676475:0.443018:0.660693:0.076185:0.660693:0.005125:0.009223:0.009827:0.004188:0.014182:0.010326:0.003069:0.009903:0.004551:0.003024:0.005125:0.008104:0.004188:0.004551:0.009827:0.005866:0.009903:0.003024:0.008376:0.009827:0.004188:0.004188:0.008376:0.008376:0.005020:0.008376:0.008376:0.011717:0.004188:0.010311:0.009827:0.004551:0.005866:0.003024:0.005866:0.005125:0.004188:0.003024:0.009223:0.005125:0.009903:0.004188:0.010326:0.010357:0.009192:0.003024:0.005125:0.009223:0.009903:0.009903:0.010357:0.004188
4:@0.443004:0.671190:0.447862:0.671190:0.447862:0.662036:0.443004:0.662036:0.004858
imPACt On sOCiety:@0.076190:0.709475:0.257283:0.709475:0.257283:0.689310:0.076190:0.689310:0.005174:0.016631:0.010348:0.013674:0.014413:0.007761:0.005174:0.015522:0.013674:0.005174:0.009609:0.015522:0.014413:0.005174:0.009609:0.007761:0.011457
Atopic dermatitis is associated with significant morbidity :@0.076190:0.725492:0.485160:0.725492:0.485160:0.709710:0.076190:0.709710:0.011037:0.004974:0.009752:0.010160:0.002873:0.009631:0.005110:0.010205:0.009676:0.004400:0.014030:0.010175:0.004974:0.002873:0.004974:0.002873:0.005715:0.005110:0.002873:0.005715:0.005110:0.010175:0.005715:0.005715:0.009752:0.009631:0.002873:0.010175:0.004974:0.009676:0.010205:0.005110:0.012413:0.002873:0.004974:0.009071:0.005110:0.005715:0.002873:0.010024:0.009071:0.002873:0.003606:0.003606:0.009631:0.010175:0.009071:0.004974:0.005110:0.014030:0.009752:0.004400:0.010160:0.002873:0.010205:0.002873:0.004974:0.008104:0.004188
and can profoundly impact quality of life (QOL). The lack :@0.076190:0.739728:0.485100:0.739728:0.485100:0.723945:0.076190:0.723945:0.010175:0.009071:0.010205:0.003477:0.009631:0.010175:0.009071:0.003477:0.010160:0.004400:0.009752:0.004596:0.009752:0.009041:0.009071:0.010205:0.002873:0.007953:0.003477:0.002873:0.014030:0.010160:0.010175:0.009631:0.004974:0.003477:0.010160:0.009041:0.010175:0.002873:0.002873:0.004974:0.007953:0.003477:0.009752:0.004596:0.003477:0.002873:0.002873:0.004596:0.009676:0.003477:0.005428:0.013017:0.012987:0.006834:0.005428:0.004037:0.003477:0.006290:0.009071:0.009676:0.003477:0.002873:0.010175:0.009631:0.007590:0.004188
of sleep from relentless pruritus affects both patient and :@0.076190:0.753963:0.485115:0.753963:0.485115:0.738181:0.076190:0.738181:0.009752:0.004596:0.004929:0.005715:0.002873:0.009676:0.009676:0.010160:0.004929:0.004596:0.004400:0.009752:0.014030:0.004929:0.004400:0.009676:0.002873:0.009676:0.009071:0.004974:0.002873:0.009676:0.005715:0.005715:0.004929:0.010160:0.004400:0.009041:0.004400:0.002873:0.004974:0.009041:0.005715:0.004929:0.010175:0.004596:0.004596:0.009676:0.009631:0.004974:0.005715:0.004929:0.010160:0.009752:0.004974:0.009071:0.004929:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.004929:0.010175:0.009071:0.010357:0.004188
caregiver, as well as functioning at school and work.:@0.076190:0.768199:0.451777:0.768199:0.451777:0.752416:0.076190:0.752416:0.009631:0.010175:0.004400:0.009676:0.010024:0.002873:0.008225:0.009676:0.004400:0.004037:0.004037:0.010175:0.005715:0.004037:0.012413:0.009676:0.002873:0.002873:0.004037:0.010175:0.005715:0.004037:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009071:0.002873:0.009071:0.010024:0.004037:0.010175:0.004974:0.004037:0.005715:0.009631:0.009071:0.009752:0.009752:0.002873:0.004037:0.010175:0.009071:0.010205:0.004037:0.012413:0.009752:0.004400:0.007439:0.004188
PAtHOPHysiOlOGy:@0.076190:0.801195:0.251370:0.801195:0.251370:0.781030:0.076190:0.781030:0.010348:0.013674:0.007761:0.012566:0.015522:0.010348:0.012566:0.011457:0.009609:0.005174:0.015522:0.008131:0.015522:0.015522:0.011457
Atopic dermatitis is a chronic multifactorial disease, result-:@0.076190:0.817212:0.480912:0.817212:0.480912:0.801429:0.076190:0.801429:0.010886:0.004823:0.009601:0.010009:0.002721:0.009480:0.004052:0.010054:0.009525:0.004248:0.013879:0.010024:0.004823:0.002721:0.004823:0.002721:0.005564:0.004052:0.002721:0.005564:0.004052:0.010024:0.004052:0.009480:0.008920:0.004248:0.009601:0.008920:0.002721:0.009480:0.004052:0.013879:0.008890:0.002721:0.004823:0.002721:0.004445:0.010024:0.009480:0.004823:0.009601:0.004248:0.002721:0.010024:0.002721:0.004052:0.010054:0.002721:0.005564:0.009525:0.010024:0.005564:0.009525:0.003886:0.004052:0.004248:0.009525:0.005564:0.008890:0.002721:0.004823:0.005020
ing from a dysfunctional skin barrier and immune respons-:@0.076190:0.831448:0.480942:0.831448:0.480942:0.815665:0.076190:0.815665:0.002721:0.008920:0.009873:0.004037:0.004445:0.004248:0.009601:0.013879:0.004037:0.010024:0.004037:0.010054:0.007801:0.005564:0.004445:0.008890:0.008920:0.009480:0.004823:0.002721:0.009601:0.008920:0.010024:0.002721:0.004037:0.005564:0.007287:0.002721:0.008920:0.004037:0.010009:0.010024:0.004248:0.004248:0.002721:0.009525:0.004248:0.004037:0.010024:0.008920:0.010054:0.004037:0.002721:0.013879:0.013879:0.008890:0.008920:0.009525:0.004037:0.004248:0.009525:0.005564:0.010009:0.009601:0.008920:0.005564:0.005020
es that are influenced by genetic and environmental fac:@0.076190:0.845683:0.476255:0.845683:0.476255:0.829901:0.076190:0.829901:0.009525:0.005564:0.003704:0.004823:0.008920:0.010024:0.004823:0.003719:0.010024:0.004248:0.009525:0.003704:0.002721:0.008920:0.003515:0.003515:0.008890:0.009525:0.008920:0.009480:0.009525:0.010054:0.003719:0.010009:0.007801:0.003719:0.009873:0.009525:0.008920:0.009525:0.004823:0.002721:0.009480:0.003719:0.010024:0.008920:0.010054:0.003704:0.009525:0.008920:0.008074:0.002721:0.004248:0.009601:0.008920:0.013879:0.009525:0.008920:0.004823:0.010024:0.002721:0.003704:0.004445:0.010024:0.009782
-:@0.475953:0.845683:0.480972:0.845683:0.480972:0.829901:0.475953:0.829901:0.005020
tors. A strong family history of atopy and loss of function :@0.076190:0.859919:0.485130:0.859919:0.485130:0.844136:0.076190:0.844136:0.004823:0.009601:0.004248:0.005564:0.003886:0.005655:0.010886:0.005655:0.005564:0.004823:0.004248:0.009601:0.008920:0.009873:0.005655:0.004445:0.010024:0.013879:0.002721:0.002721:0.007801:0.005655:0.008920:0.002721:0.005564:0.004823:0.009601:0.004248:0.007801:0.005655:0.009601:0.004445:0.005655:0.010024:0.004823:0.009601:0.010009:0.007801:0.005655:0.010024:0.008920:0.010054:0.005655:0.002721:0.009601:0.005564:0.005564:0.005655:0.009601:0.004445:0.005655:0.004445:0.008890:0.008920:0.009480:0.004823:0.002721:0.009601:0.009223:0.004188
mutations in the filaggrin gene have been strongly asso:@0.076190:0.874154:0.476301:0.874154:0.476301:0.858372:0.076190:0.858372:0.013879:0.008890:0.004823:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.005443:0.002721:0.008920:0.005443:0.004823:0.008920:0.009525:0.005443:0.003530:0.003530:0.002721:0.010024:0.009873:0.009873:0.004248:0.002721:0.008920:0.005443:0.009873:0.009525:0.008920:0.009525:0.005443:0.008920:0.010024:0.008074:0.009525:0.005443:0.010009:0.009525:0.009525:0.008920:0.005443:0.005564:0.004823:0.004248:0.009601:0.008920:0.009873:0.002721:0.007801:0.005443:0.010024:0.005564:0.005564:0.009903
-:@0.475998:0.874154:0.481018:0.874154:0.481018:0.858372:0.475998:0.858372:0.005020
ciated with atopic dermatitis development. Other asso-:@0.076190:0.888390:0.480987:0.888390:0.480987:0.872607:0.076190:0.872607:0.009480:0.002721:0.010024:0.004823:0.009525:0.010054:0.006290:0.012262:0.002721:0.004823:0.008920:0.006290:0.010024:0.004823:0.009601:0.010009:0.002721:0.009480:0.006290:0.010054:0.009525:0.004248:0.013879:0.010024:0.004823:0.002721:0.004823:0.002721:0.005564:0.006290:0.010054:0.009525:0.008074:0.009525:0.002721:0.009601:0.010009:0.013879:0.009525:0.008920:0.004823:0.003886:0.006290:0.012836:0.004823:0.008920:0.009525:0.004248:0.006290:0.010024:0.005564:0.005564:0.009601:0.005020
ciated genes include claudin-1 (CLDN1) and serine pro-:@0.076190:0.902625:0.480912:0.902625:0.480912:0.886843:0.076190:0.886843:0.009480:0.002721:0.010024:0.004823:0.009525:0.010054:0.005609:0.009873:0.009525:0.008920:0.009525:0.005564:0.005609:0.002721:0.008920:0.009480:0.002721:0.008890:0.010054:0.009525:0.005609:0.009480:0.002721:0.010024:0.008890:0.010054:0.002721:0.008920:0.004717:0.008074:0.005609:0.005277:0.011989:0.006683:0.010946:0.010886:0.008074:0.005277:0.005609:0.010024:0.008920:0.010054:0.005609:0.005564:0.009525:0.004248:0.002721:0.008920:0.009525:0.005609:0.010009:0.004248:0.009601:0.005020
tease inhibitor Kazal-Type (spINK5). Immune responses in :@0.076190:0.916861:0.485130:0.916861:0.485130:0.901078:0.076190:0.901078:0.004823:0.009525:0.010024:0.005564:0.009525:0.005866:0.002721:0.008920:0.008920:0.002721:0.010009:0.002721:0.004823:0.009601:0.004248:0.005866:0.008633:0.010024:0.006123:0.010024:0.002721:0.004717:0.006138:0.007801:0.010009:0.009525:0.005866:0.005277:0.007227:0.008648:0.003115:0.010886:0.008633:0.008074:0.005277:0.003886:0.005866:0.003115:0.013879:0.013879:0.008890:0.008920:0.009525:0.005866:0.004248:0.009525:0.005564:0.010009:0.009601:0.008920:0.005564:0.009525:0.005564:0.005866:0.002721:0.009223:0.004188
atopic dermatitis are characterised by an increase in T 2 :@0.076190:0.931096:0.485137:0.931124:0.485137:0.915341:0.076190:0.915314:0.010024:0.004823:0.009601:0.010009:0.002721:0.009480:0.004823:0.010054:0.009525:0.004248:0.013879:0.010024:0.004823:0.002721:0.004823:0.002721:0.005564:0.004823:0.010024:0.004248:0.009525:0.004823:0.009480:0.008920:0.010024:0.004248:0.010024:0.009480:0.004823:0.009525:0.004248:0.002721:0.005564:0.009525:0.010054:0.004823:0.010009:0.007801:0.004823:0.010024:0.008920:0.004823:0.002721:0.008920:0.009480:0.004248:0.009525:0.010024:0.005564:0.009525:0.004823:0.002721:0.008920:0.004823:0.006441:0.005480:0.008376:-0.370086
H:@0.466758:0.930790:0.472748:0.930790:0.472748:0.921636:0.466758:0.921636:0.005989
and T 17 responses.:@0.076197:0.945359:0.213763:0.945363:0.213763:0.929580:0.076197:0.929577:0.010024:0.008920:0.010054:0.003886:0.006441:0.005500:0.008074:0.008074:0.003886:0.004248:0.009525:0.005564:0.010009:0.009601:0.008920:0.005564:0.009525:0.005564:-0.117358
H:@0.115208:0.945028:0.121197:0.945028:0.121197:0.935875:0.115208:0.935875:0.005989
DiAGnOstiC issues:@0.519047:0.171280:0.693118:0.171280:0.693118:0.151115:0.519047:0.151115:0.012935:0.005174:0.013674:0.015522:0.013674:0.015522:0.009609:0.007761:0.005174:0.014413:0.005174:0.005174:0.009609:0.009609:0.011826:0.009609:0.009609
Atopic dermatitis is a clinical diagnosis as there are cur-:@0.519047:0.187169:0.923799:0.187169:0.923799:0.171386:0.519047:0.171386:0.011188:0.005125:0.009903:0.010311:0.003024:0.009782:0.004203:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004203:0.003024:0.005866:0.004203:0.010326:0.004203:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004218:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004203:0.010326:0.005866:0.004203:0.005125:0.009223:0.009827:0.004551:0.009827:0.004188:0.010326:0.004551:0.009827:0.004203:0.009782:0.009192:0.004551:0.005020
rently no reliable biomarkers. Numerous diagnostic cri-:@0.519047:0.201277:0.923799:0.201277:0.923799:0.185495:0.519047:0.185495:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.005745:0.009223:0.009903:0.005745:0.004551:0.009827:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.005745:0.010311:0.003024:0.009903:0.014182:0.010326:0.004551:0.007590:0.009827:0.004551:0.005866:0.004188:0.005745:0.011188:0.009192:0.014182:0.009827:0.004551:0.009903:0.009192:0.005866:0.005730:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.005125:0.003024:0.009782:0.005745:0.009782:0.004551:0.003024:0.005020
teria, mainly for use in clinical trials, exist. The revised UK :@0.519047:0.215386:0.927987:0.215386:0.927987:0.199603:0.519047:0.199603:0.005125:0.009827:0.004551:0.003024:0.010326:0.004188:0.004475:0.014182:0.010326:0.003024:0.009223:0.003024:0.008104:0.004475:0.004747:0.009903:0.004551:0.004460:0.009192:0.005866:0.009827:0.004475:0.003024:0.009223:0.004475:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004490:0.005125:0.004551:0.003024:0.010326:0.003024:0.005866:0.004188:0.004475:0.009827:0.007257:0.003024:0.005866:0.005125:0.004188:0.004475:0.006441:0.009223:0.009827:0.004460:0.004551:0.009827:0.008376:0.003024:0.005866:0.009827:0.010357:0.004475:0.009903:0.008935:0.004188
Working party criteria have been validated in hospital :@0.519047:0.229494:0.927972:0.229494:0.927972:0.213712:0.519047:0.213712:0.014514:0.009903:0.004551:0.007590:0.003024:0.009223:0.010175:0.005957:0.008950:0.010326:0.004551:0.005125:0.008104:0.005957:0.009782:0.004551:0.003024:0.005125:0.009827:0.004551:0.003024:0.010326:0.005972:0.009223:0.010326:0.008376:0.009827:0.005972:0.010311:0.009827:0.009827:0.009223:0.005957:0.008376:0.010326:0.003024:0.003024:0.010357:0.010326:0.005125:0.009827:0.010357:0.005972:0.003024:0.009223:0.005972:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.004188
and community settings (see Figure 1).:@0.519047:0.243603:0.800186:0.243603:0.800186:0.227820:0.519047:0.227820:0.010326:0.009223:0.010357:0.004188:0.009782:0.009903:0.014182:0.014182:0.009192:0.009223:0.003024:0.005125:0.008104:0.004188:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.005866:0.004188:0.005579:0.005866:0.009827:0.009827:0.004188:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.004188:0.008376:0.005579:0.004188
Acute atopic dermatitis is characterised by erythema, :@0.533335:0.502960:0.928002:0.502960:0.928002:0.487177:0.533335:0.487177:0.011188:0.009782:0.009192:0.005125:0.009827:0.003372:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.003372:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.003372:0.003024:0.005866:0.003387:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.009827:0.010357:0.003372:0.010311:0.008104:0.003387:0.009827:0.004551:0.008104:0.005125:0.009223:0.009827:0.014182:0.010326:0.004188:0.004188
oedema, vesiculation, weeping and crusting. Chronic :@0.519047:0.517265:0.928002:0.517265:0.928002:0.501482:0.519047:0.501482:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.004188:0.006259:0.008376:0.009827:0.005866:0.003024:0.009782:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.006259:0.012564:0.009827:0.009827:0.010311:0.003024:0.009223:0.010175:0.006259:0.010326:0.009223:0.010357:0.006259:0.009782:0.004551:0.009192:0.005866:0.005125:0.003024:0.009223:0.010175:0.004188:0.006259:0.012292:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004188
disease is characterised by dry, scaly, thick, lichenified :@0.519047:0.531569:0.928002:0.531569:0.928002:0.515787:0.519047:0.515787:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005397:0.003024:0.005866:0.005382:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.009827:0.010357:0.005382:0.010311:0.008104:0.005382:0.010357:0.004551:0.008104:0.004188:0.005382:0.005866:0.009782:0.010326:0.003024:0.008104:0.004188:0.005397:0.005125:0.009223:0.003024:0.009782:0.007590:0.004188:0.005382:0.003024:0.003024:0.009782:0.009223:0.009827:0.009223:0.003024:0.003681:0.003681:0.009827:0.010357:0.004188
and fissured skin. There is an age-dependent distribution :@0.519047:0.545874:0.927987:0.545874:0.927987:0.530092:0.519047:0.530092:0.010326:0.009223:0.010357:0.003644:0.003681:0.003681:0.005866:0.005866:0.009192:0.004551:0.009827:0.010357:0.003644:0.005866:0.007590:0.003024:0.009223:0.004188:0.003644:0.006441:0.009223:0.009827:0.004551:0.009827:0.003629:0.003024:0.005866:0.003644:0.010326:0.009223:0.003644:0.010326:0.010175:0.009827:0.005020:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.009827:0.009223:0.005125:0.003629:0.010357:0.003024:0.005866:0.005125:0.004551:0.003024:0.010311:0.009192:0.005125:0.003024:0.009903:0.009223:0.004188
of atopic dermatitis. In children under two years of age, :@0.519047:0.560179:0.927987:0.560179:0.927987:0.544396:0.519047:0.544396:0.009903:0.004747:0.003976:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.003976:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004188:0.003991:0.003417:0.009223:0.003976:0.009782:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.003976:0.009192:0.009223:0.010357:0.009827:0.004551:0.003976:0.005125:0.012564:0.009903:0.003976:0.008104:0.009827:0.010326:0.004551:0.005866:0.003976:0.009903:0.004747:0.003976:0.010326:0.010175:0.009827:0.004188:0.004188
atopic dermatitis is commonly distributed on the face :@0.519047:0.574484:0.927987:0.574484:0.927987:0.558701:0.519047:0.558701:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.006138:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.006138:0.003024:0.005866:0.006138:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.003024:0.008104:0.006138:0.010357:0.003024:0.005866:0.005125:0.004551:0.003024:0.010311:0.009192:0.005125:0.009827:0.010357:0.006138:0.009903:0.009223:0.006123:0.005125:0.009223:0.009827:0.006123:0.004747:0.010326:0.009782:0.009827:0.004188
and extensor surfaces (see Figure 2).:@0.519047:0.588789:0.784976:0.588789:0.784976:0.573006:0.519047:0.573006:0.010326:0.009223:0.010357:0.004188:0.009827:0.007257:0.005125:0.009827:0.009223:0.005866:0.009903:0.004551:0.004188:0.005866:0.009192:0.004551:0.004747:0.010326:0.009782:0.009827:0.005866:0.004188:0.005579:0.005866:0.009827:0.009827:0.004188:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.004188:0.008376:0.005579:0.004188
figure 2. facial involvement with nasal-sparing :@0.519047:0.844141:0.864971:0.844141:0.864971:0.827642:0.519047:0.827642:0.007257:0.003629:0.009979:0.009071:0.004838:0.009676:0.004233:0.008467:0.004233:0.004233:0.007257:0.009979:0.009676:0.003629:0.009979:0.003629:0.004233:0.003629:0.009071:0.008467:0.009676:0.003629:0.008467:0.009676:0.014212:0.009676:0.009071:0.004536:0.004233:0.012095:0.003629:0.004536:0.009071:0.004233:0.009071:0.009979:0.006652:0.009979:0.003629:0.006350:0.006652:0.009979:0.009979:0.004838:0.003629:0.009071:0.009979:0.004233
in the infantile phase:@0.519047:0.858445:0.670540:0.858445:0.670540:0.841947:0.519047:0.841947:0.003629:0.009071:0.004233:0.004536:0.009071:0.009676:0.004233:0.003629:0.009071:0.004233:0.009979:0.009071:0.004536:0.003629:0.003629:0.009676:0.004233:0.009979:0.009071:0.009979:0.006652:0.009676
In  individuals  older  than  two  years,  it is distributed :@0.533335:0.888140:0.927987:0.888140:0.927987:0.872358:0.533335:0.872358:0.003417:0.009223:0.004188:0.004082:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.005866:0.004188:0.004112:0.009903:0.003024:0.010357:0.009827:0.004551:0.004188:0.004082:0.005125:0.009223:0.010326:0.009223:0.004188:0.004082:0.005125:0.012564:0.009903:0.004188:0.004082:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.004188:0.004082:0.003024:0.005125:0.008285:0.003024:0.005866:0.008285:0.010357:0.003024:0.005866:0.005125:0.004551:0.003024:0.010311:0.009192:0.005125:0.009827:0.010357:0.004188
more on flexor surfaces, including the cubital and pop:@0.519047:0.902445:0.918779:0.902445:0.918779:0.886663:0.519047:0.886663:0.014182:0.009903:0.004551:0.009827:0.004566:0.009903:0.009223:0.004566:0.003666:0.003666:0.009827:0.007257:0.009903:0.004551:0.004551:0.005866:0.009192:0.004551:0.004747:0.010326:0.009782:0.009827:0.005866:0.004188:0.004566:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.004566:0.005125:0.009223:0.009827:0.004566:0.009782:0.009192:0.010311:0.003024:0.005125:0.010326:0.003024:0.004566:0.010326:0.009223:0.010357:0.004566:0.010311:0.009903:0.010311
-:@0.918779:0.902445:0.923799:0.902445:0.923799:0.886663:0.918779:0.886663:0.005020
liteal fossae,  anterior  neck  and  gluteal creases.  How-:@0.519047:0.916750:0.923799:0.916750:0.923799:0.900967:0.519047:0.900967:0.003024:0.003024:0.005125:0.009827:0.010326:0.003024:0.006879:0.004747:0.009903:0.005866:0.005866:0.010326:0.009827:0.004188:0.004188:0.002676:0.010326:0.009223:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.004188:0.002676:0.009223:0.009827:0.009782:0.007590:0.004188:0.002676:0.010326:0.009223:0.010357:0.004188:0.002676:0.010175:0.003024:0.009192:0.005125:0.009827:0.010326:0.003024:0.006879:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005866:0.004188:0.004188:0.002676:0.010326:0.009903:0.012564:0.005020
ever, any bold fold may be affected (see Figure 3). In :@0.519047:0.931055:0.927972:0.931055:0.927972:0.915272:0.519047:0.915272:0.009827:0.008376:0.009827:0.004551:0.004188:0.005518:0.010326:0.009223:0.008104:0.005518:0.010311:0.009903:0.003024:0.010357:0.005518:0.004747:0.009903:0.003024:0.010357:0.005518:0.014182:0.010326:0.008104:0.005534:0.010311:0.009827:0.005518:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.009827:0.010357:0.005518:0.005579:0.005866:0.009827:0.009827:0.005518:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.005518:0.008376:0.005579:0.004188:0.005534:0.003417:0.009223:0.004188
adults, the face and hands are commonly involved.:@0.519047:0.945360:0.899503:0.945360:0.899503:0.929577:0.519047:0.929577:0.010326:0.010357:0.009192:0.003024:0.005125:0.005866:0.004188:0.004188:0.005125:0.009223:0.009827:0.004188:0.004747:0.010326:0.009782:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.009223:0.010326:0.009223:0.010357:0.005866:0.004188:0.010326:0.004551:0.009827:0.004188:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.003024:0.008104:0.004188:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.009827:0.010357:0.004188
•  Must have::@0.532488:0.282547:0.632848:0.282547:0.632848:0.266764:0.532488:0.266764:0.009162:0.004188:0.006804:0.013894:0.009192:0.005866:0.005125:0.004188:0.009223:0.010326:0.008376:0.009827:0.004188
•  Pruritus/itching:@0.532488:0.296656:0.659276:0.296656:0.659276:0.280873:0.532488:0.280873:0.009162:0.004188:0.006804:0.008950:0.004551:0.009192:0.004551:0.003024:0.005125:0.009192:0.005866:0.006607:0.003024:0.005125:0.009782:0.009223:0.003024:0.009223:0.010175
Plus three or more of the following::@0.532488:0.310764:0.784719:0.310764:0.784719:0.294981:0.532488:0.294981:0.008950:0.003024:0.009192:0.005866:0.004188:0.005125:0.009223:0.004551:0.009827:0.009827:0.004188:0.009903:0.004551:0.004188:0.014182:0.009903:0.004551:0.009827:0.004188:0.009903:0.004747:0.004188:0.005125:0.009223:0.009827:0.004188:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.004188
•  Visible flexural dermatitis (front of elbows, back of :@0.532488:0.324873:0.917918:0.324873:0.917918:0.309090:0.532488:0.309090:0.009162:0.004188:0.006804:0.010614:0.003024:0.005866:0.003024:0.010311:0.003024:0.009827:0.004354:0.003666:0.003666:0.009827:0.007257:0.009192:0.004551:0.010326:0.003024:0.004324:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004339:0.005579:0.004747:0.004551:0.009903:0.009223:0.005125:0.004324:0.009903:0.004747:0.004339:0.009827:0.003024:0.010311:0.009903:0.012564:0.005866:0.004188:0.004339:0.010311:0.010326:0.009782:0.007590:0.004339:0.009903:0.004747:0.004188
knees, front of neck, around eyes) or involvement :@0.552642:0.338981:0.917918:0.338981:0.917918:0.323199:0.552642:0.323199:0.007590:0.009223:0.009827:0.009827:0.005866:0.004188:0.004067:0.004747:0.004551:0.009903:0.009223:0.005125:0.004052:0.009903:0.004747:0.004067:0.009223:0.009827:0.009782:0.007590:0.004188:0.004052:0.010326:0.004551:0.009903:0.009192:0.009223:0.010357:0.004067:0.009827:0.008104:0.009827:0.005866:0.005579:0.004067:0.009903:0.004551:0.004067:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188
of  cheeks  and/or  extensors  in  children  up  to  18 :@0.552642:0.353090:0.917887:0.353090:0.917887:0.337307:0.552642:0.337307:0.009903:0.004747:0.004188:0.002480:0.009782:0.009223:0.009827:0.009827:0.007590:0.005866:0.004188:0.002480:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.004188:0.002480:0.009827:0.007257:0.005125:0.009827:0.009223:0.005866:0.009903:0.004551:0.005866:0.004188:0.002480:0.003024:0.009223:0.004188:0.002480:0.009782:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.004188:0.002480:0.009192:0.010311:0.004188:0.002480:0.005125:0.009903:0.004188:0.002480:0.008376:0.008376:0.004188
months:@0.552642:0.367198:0.606163:0.367198:0.606163:0.351416:0.552642:0.351416:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866
•  History of flexural dermatitis:@0.532488:0.381307:0.749673:0.381307:0.749673:0.365524:0.532488:0.365524:0.009162:0.004188:0.006804:0.010326:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.009903:0.004747:0.004188:0.003666:0.003666:0.009827:0.007257:0.009192:0.004551:0.010326:0.003024:0.004188:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866
•  Generalised dry skin :@0.532488:0.395415:0.702955:0.395415:0.702955:0.379633:0.532488:0.379633:0.009162:0.004188:0.006804:0.013184:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.003024:0.005866:0.009827:0.010357:0.004188:0.010357:0.004551:0.008104:0.004188:0.005866:0.007590:0.003024:0.009223:0.004188
•  Onset less than two years of age:@0.532488:0.409524:0.790676:0.409524:0.790676:0.393741:0.532488:0.393741:0.009162:0.004188:0.006804:0.013138:0.009223:0.005866:0.009827:0.005125:0.004188:0.003024:0.009827:0.005866:0.005866:0.004188:0.005125:0.009223:0.010326:0.009223:0.004188:0.005125:0.012564:0.009903:0.004188:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.009903:0.004747:0.004188:0.010326:0.010175:0.009827
•  Personal  history  of  asthma  or  allergic  rhinitis  (or :@0.532488:0.423632:0.917918:0.423632:0.917918:0.407850:0.532488:0.407850:0.009162:0.004188:0.006804:0.008950:0.009827:0.004551:0.005866:0.009903:0.009223:0.010326:0.003024:0.004188:0.003326:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.003326:0.009903:0.004747:0.004188:0.003326:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004188:0.003341:0.009903:0.004551:0.004188:0.003326:0.010326:0.003024:0.003024:0.009827:0.004551:0.010175:0.003024:0.009782:0.004188:0.003341:0.004551:0.009223:0.003024:0.009223:0.003024:0.005125:0.003024:0.005866:0.004188:0.003341:0.005579:0.009903:0.004551:0.004188
family history of atopy in younger than four years):@0.552642:0.437741:0.913533:0.437741:0.913533:0.421958:0.552642:0.421958:0.004747:0.010326:0.014182:0.003024:0.003024:0.008104:0.004188:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.009903:0.004747:0.004188:0.010326:0.005125:0.009903:0.010311:0.008104:0.004188:0.003024:0.009223:0.004188:0.008104:0.009903:0.009192:0.009223:0.010175:0.009827:0.004551:0.004188:0.005125:0.009223:0.010326:0.009223:0.004188:0.004747:0.009903:0.009192:0.004551:0.004188:0.008104:0.009827:0.010326:0.004551:0.005866:0.005579
figure 1. revised uK Working Party criteria for the diag-:@0.519047:0.460739:0.923829:0.460739:0.923829:0.444241:0.519047:0.444241:0.007106:0.003477:0.009827:0.008920:0.004687:0.009525:0.005549:0.008315:0.004082:0.005549:0.008618:0.009525:0.008315:0.003477:0.006501:0.009525:0.009827:0.005549:0.009525:0.009223:0.005549:0.013456:0.009525:0.004687:0.008618:0.003477:0.008920:0.009827:0.005549:0.008315:0.009827:0.004687:0.004385:0.008618:0.005549:0.009525:0.004687:0.003477:0.004385:0.009525:0.004687:0.003477:0.009827:0.005549:0.004082:0.009525:0.004687:0.005549:0.004385:0.008920:0.009525:0.005549:0.009827:0.003477:0.009827:0.009827:0.006350
nosis of atopic dermatitis:@0.519047:0.474848:0.696696:0.474848:0.696696:0.458350:0.519047:0.458350:0.008920:0.009525:0.006501:0.003477:0.006501:0.004082:0.009525:0.004082:0.004082:0.009827:0.004385:0.009525:0.009827:0.003477:0.009525:0.004082:0.009827:0.009525:0.004687:0.014061:0.009827:0.004385:0.003477:0.004385:0.003477:0.006652